Delivery Order SPE2DB20D3303-SPE2DB25FA3CQ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,613.50 to AmerisourceBergen Drug Corp for the supply of BOTOX 200 Unit Vials on August 8, 2025, with an ultimate completion date of August 29, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order valued at $7,227.00 to AmerisourceBergen Drug Corp for the supply of Botox 200 unit vials, with an ultimate completion date of August 25, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded through open competition. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary operations. This delivery order is issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $4,306.80 delivery order on August 5, 2025, for BOTOX 100 Unit Vials, with an ultimate completion date of August 26, 2025. This firm fixed-price contract is unclassified as a set-aside and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply framework with the federal government. The product will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for supply of Botox 200 unit vials under a firm fixed price contract valued at $3,011.25. The order, issued on August 1, 2025, with an ultimate completion date of August 22, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this delivery from its corporate office location....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of BOTOX 100 unit vials with a ceiling value of $1,722.72. This firm fixed price delivery order represents a non-set-aside competitive award with an ultimate completion date of August 25, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $42,739.50 to AmerisourceBergen Drug Corp for supply of Botox 200 unit vials, with a completion date of August 20, 2025. This competitive award, issued on July 30, 2025, carries no set-aside designation and employs firm fixed pricing terms. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's broader Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of BOTOX 100 unit vials with a ceiling value of $8,613.60. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is scheduled for completion by August 20, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $2,564.37 to supply Botox 200 unit vials, with an ultimate completion date of August 20, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, meaning it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of BOTOX 100 Unit Vials with a ceiling value of $10,336.32. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the company's demonstrated capability to compete in...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Botox 200 Unit Vials, valued at $5,128.74 under a firm fixed price contract structure. The award, issued on July 25, 2025, with an ultimate completion date of August 15, 2025, represents a competitive procurement with no set-aside designation. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen Drug...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA3CQDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Botox Cosmetic 100 Unit Vials under a firm fixed-price contract with a ceiling value of $3,574.80. The award was made on September 2, 2025, with an ultimate completion date of September 23, 2025. This non-set-aside delivery order was competitively awarded and represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal medical procurement programs, with performance to be conducted at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion global pharmaceutical support vehicle that runs through December 2026. The IDC serves as the primary contracting mechanism through which AmerisourceBergen supplies an extensive range of pharmaceutical products and medical commodities to support military healthcare systems, the Defense Health Agency, the U.S. Coast Guard, and other federal healthcare entities worldwide. The company's track record of competitive awards with firm fixed pricing across multiple therapeutic domains demonstrates its established capability to fulfill federal medical supply requirements efficiently and cost-effectively.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 9/2/25 |